glp-1 sglt2 receptor agonists and inhibitors: a couple at last? Complementary Yet Distinct Roles of

PolicyLab Exclusive Rate with Embody PolicyLab readers get exclusive pricing at Embody through our preferred-partner status

Tirzepatide works by activating GIP and GLP-1 receptor pathways

When comparing data from rodents with humans, results regarding GLP-1s renal effects are very different

Morganville / Marlboro and Monmouth County residents seeking semaglutide or tirzepatide treatment benefit from physician-directed care that prioritizes safety, measurable progress, and accountability

We know from leading scientific bodies, including the World Health Organization, that GLP-1 medications are powerful tools, but not standalone solutions

De Block has received personal fees from AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Lilly, Merck Sharp & Dohme, Novo Nordisk A/S, and Sanofi